66 National Security Strategy and Strategic Defence and Security Review
5.132 We set up the International Climate Fund to provide £3.87 billion in international climate
finance between April 2011 and March 2016, helping the world’s poorest to adapt to climate
change and promote cleaner, greener growth. We will increase UK climate finance for
developing countries by at least 50%, rising to £5.8 billion over five years, to reduce
emissions, increase access to energy, build resilience of the poorest and most vulnerable
people, and reduce deforestation. This will in turn help reduce global impacts and reduce the
costs of responding to disasters.
5.133 We will continue to focus diplomatic effort on driving global action to reduce emissions
through national policies, bilateral cooperation and negotiations under the UN Framework
Convention on Climate Change. We will work with partners to manage the consequences of
climate change, including for our strategic interests such as in the Polar regions.
5.134 Our businesses, institutions and public bodies are world leaders in tackling and
adapting to climate change. We will support them in exploring opportunities to export
UK expertise to countries developing their own mitigation and adaptation policies.
Global health security
5.135 Health crises can have regional and international impact. Diseases can spread rapidly,
including across borders. The emergence of drug-resistant disease is an increasing global
threat. A comprehensive approach overseas and at home is critical to protect British nationals
and our wider interests, and to mitigate the impact of health threats in other countries.
5.136 We will build on our international action to strengthen global health security, such as
our leading contribution to combating the Ebola outbreak in West Africa. We will increase
our investment, making greater use of the UK’s world-leading expertise in public health and
medical research.
5.137 We have led the global fight against Antimicrobial Resistance. In March 2015 we
announced the new £195 million Fleming Fund to strengthen surveillance of drug resistance
and laboratory capacity in developing countries. We will implement the UK AMR Strategy
2013–18 and deliver the new AMR Innovation Fund launched with China, bringing in a broad
range of international partners. We will lobby for further international financing for research and
innovation to tackle AMR over this Parliament.
5.138 We have established a £20 million UK Vaccines Network to bring together the best
expertise from academia, philanthropic organisations and industry for developing and trialling
new vaccines for infectious diseases. We will invest further in the UK Vaccines Network up to
2020.
5.139 We will also invest in new, large-scale research and development to combat the
world’s deadliest diseases. These include diseases with epidemic potential and those which
affect the lives and livelihoods of millions in developing countries, building on the UK’s major
commitment to tackle malaria and neglected tropical diseases over the last Parliament.
5.140 We will establish a new rapid response team of technical experts to deploy
to help countries to investigate and control disease outbreaks. This team will include
epidemiologists, infection control specialists and researchers and will be on permanent
standby. We will expand our Emergency Medical Team to provide medical assistance to
help contain outbreaks when needed, including hundreds of doctors, nurses and specialist
public health experts with field training.
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents